FDA Inspection 1014186 — Rex Medical LP

Rex Medical LP — FEI 3003862657

The FDA completed an inspection of Rex Medical LP on April 19, 2017 in Conshohocken, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 19, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Conshohocken, PA (United States)

Additional Details

Postmarket Audit Inspections

Citations

IDCFRDescription
1472121 CFR 820.70(g)(2)Periodic equipment inspections
263021 CFR 820.30(e)Design review - documentation